Back to catalog
FGFR3Rare
Infigratinib
4.9 / 5High PurityPharma GradeLab TestedResearch Only
Infigratinib is a selective FGFR3 kinase inhibitor researched for chondrocyte signaling in achondroplasia and FGFR-driven oncology models. Laboratory work maps receptor phosphorylation blockade, growth-plate biology, and downstream STAT pathway modulation.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
INF1G
Peptide1g powder
$370
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord